Replies to post #222562 on Biotech Values

[DewDiligence]

ENTA’s pro forma cash @12/31/18=$412.2M—an increase of $31.4M since 9/30/18 (#msg-145176830).

The $412.2M figure above consists of: $400.7 of net current assets on the 12/31/18 balance sheet (https://www.sec.gov/Archives/edgar/data/1177648/000156459019002428/enta-10q_20181231.htm#CONSOLIDATED_BALANCE_SHEETS ); and $11.5M of marketable securities on the 12/31/18 balance sheet designated as non-current (e.g. US Treasury securities with a maturity of more than 1 year).